AGP Executive Report
Last update: 5 hours agoHantavirus Watch: Cyprus has activated the EU Council’s crisis response system for information-sharing as hantavirus cases draw attention worldwide, though the ECDC still rates the risk to the public in Europe as “very low” and says the virus doesn’t spread easily between people. Fake Medicines Crackdown: Cyprus also joined a Eurojust/Europol operation across 15 countries targeting a fake-medicine and unlicensed supplement network accused of selling 400+ products online using celebrity identities and fake medical experts. Rare Disease & Innovation: In the wider health-tech world, Demis Hassabis’ Isomorphic Labs secured $2.1bn to speed up AI drug discovery, while Cyprus continues to position itself as an innovation hub via diaspora and research events. Local Health System Pressure: A major European study flags Cyprus among countries seeing hospital superbugs spread beyond isolated cases, raising the stakes for infection control. Health Policy Debate: EU leaders renewed pressure on member states over “conversion therapy,” with Cyprus listed among countries that already have bans.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
